Effects of Whole-Body Vibration Training Versus Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease

December 23, 2019 updated by: Klaus Kenn, Schön Klinik Berchtesgadener Land

Effects of a Three Week Whole Body Vibration Training Versus Conventional Balance Training in Patients With Severe Chronic Obstructive Pulmonary Disease

Aim of this study is to compare the effects of whole-body Vibration Training versus conventional Balance Training on Balance performance, gait quality and exercise capacity in patients with severe chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups. On top of a standardized endurance and strength Training program (5 days per week) patients in both groups will perform an additional Balance Training (on 3 days per week). Patients in both Groups will perform the same 4 different Balance exercises (2x1 Minute each): dynamic squats with closed eyes, heel raise, semi-Tandem stance and single leg stance but on a different surface. The Vibration Training Group will perform the exercises on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz and the control Group will perform exercises on instable objects like Balance pads. The degree of difficulty in both Groups will be individually adjusted and will be progressively increased, if possible.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Schoenau Am Koenigssee, Bavaria, Germany, 83471
        • Schön Klinik Berchtesgadener Land

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD stage III or IV according to the global initiative for chronic obstructive lung disease
  • impaired exercise capacity (6 Minute walk distance of less than 70% of the reference value from Troosters et al.)

Exclusion Criteria:

  • current acute exacerbation of COPD
  • carbon dioxide pressure of more than 45 mmHg at rest
  • any contraindication for vibration Training (e.g. acute deep vein thrombosis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Whole Body Vibration training
Balance Training on a Vibration platform
n=24 patients with severe chronic obstructive pulmonary disease. Exercises will be performed on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz.
Active Comparator: Conventional Balance training
Balance Training on a Balance board
n=24 patients with COPD, Exercises will be performed on a Balance pad

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Balance Performance during semi Tandem stance
Time Frame: measurement on Day 1 and 21
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
measurement on Day 1 and 21

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle power during counter movement jump
Time Frame: measurement on Day 1 and 21
patients jump on a force platform as high as possible. The Outcome is Watt per Kilogram Body weight
measurement on Day 1 and 21
Change in performance of the 5-Repetition-Raise-Test
Time Frame: measurement on Day 1 and 21
Patients try to perform 5 repetitions of standing up and sitting down from a chair with crossed arms on a force platform as quick as possible
measurement on Day 1 and 21
Change in performance of the 1-Minute-Chair-Rise-Test
Time Frame: measurement on Day 1 and 21
Patients try to perform as many repetitions as possible of standing up and sitting down from a chair with crossed arms on a force platform during 1 minute
measurement on Day 1 and 21
Change in Peak muscle strength of the knee Extension muscles
Time Frame: measurement on Day 1 and 21
isometric peak torque of the knee extensor muscles are measured in 90° knee angle
measurement on Day 1 and 21
Change in Peak muscle strength of the knee Flexion muscles
Time Frame: measurement on Day 1 and 21
isometric peak torque of the knee flexor muscles are measured in 90° knee angle
measurement on Day 1 and 21
Change in 6-minute Walk Distance
Time Frame: measurement on Day 1 and 21
patients are advised to walk as far as possible on a 30m track
measurement on Day 1 and 21
Change in 4m Gait Speed Test
Time Frame: measurement on Day 1 and 21
patients have to walk 4 meters at their usual Speed. Outcome is the average Speed during the 4m walk.
measurement on Day 1 and 21
Change in step symmetry during 20m walking
Time Frame: measurement on Day 1 and 21
Patients walk 20m while wearing the Mc Roberts move test device (triaxial accelerometer) which performs a gait analysis
measurement on Day 1 and 21
Change in Hospital anxiety and Depression scale
Time Frame: measurement on Day 1 and 21
the Hospital anxiety and Depression scale is a questionnaire that evaluates signs of anxiety or depression
measurement on Day 1 and 21
Change in balance performance during Romberg stance
Time Frame: measurement on Day 1 and 21
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
measurement on Day 1 and 21
Change in Balance Performance during 1-leg stance
Time Frame: measurement on Day 1 and 21
patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force.
measurement on Day 1 and 21

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Klaus Kenn, MD, Schoen Klinik Berchtesgadener Land

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2017

Primary Completion (Actual)

August 16, 2019

Study Completion (Actual)

August 16, 2019

Study Registration Dates

First Submitted

May 16, 2017

First Submitted That Met QC Criteria

May 16, 2017

First Posted (Actual)

May 17, 2017

Study Record Updates

Last Update Posted (Actual)

December 24, 2019

Last Update Submitted That Met QC Criteria

December 23, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Balance Training on a vibration platform

3
Subscribe